(Q44314655)

1 December 2017

title

Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication (English)

1 reference

prothrombin complex concentrate

1 December 2017

0 references

1 reference

1 reference

1 reference

Masahiro Yasaka

1

1 reference

1 December 2017

Toshiyuki Sakata

series ordinal

2

1 reference

1 December 2017

Kazuo Minematsu

series ordinal

3

1 reference

1 December 2017

Hiroaki Naritomi

series ordinal

4

1 reference

1 December 2017

publication date

1 October 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

108

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

25-30

1 reference

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Atrial fibrillation and stroke. Three new studies, three remaining questions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Prevention of stroke in patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Anticoagulant-related intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Intracerebral hematomas during anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Risk factors for intracranial hemorrhage in outpatients taking warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Use of factor IX complex in warfarin-related intracranial hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Emergency reversal of anticoagulation after intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Management of oral anticoagulant-induced intracranial haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

The ABCs of measuring intracerebral hemorrhage volumes.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Measurements of acute cerebral infarction: lesion size by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Predisposing factors to enlargement of spontaneous intracerebral hematoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

Management of intracranial hemorrhage associated with anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2802%2900402-4

7 January 2021

10.1016/S0049-3848(02)00402-4

Identifiers

DOI

1 reference

1 December 2017

1 reference